Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Retatrutide Phase 2 Efficacy Data The phase 2 dose-ranging trial (ClinicalTrials.gov NCT04881760, published in the New England Journal of Medicine in 2023) enrolled 338 adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity, and randomized them to placebo or retatrutide 1 mg, 4 mg, 8 mg, or 12 mg weekly after a structured titration period of up to 24 weeks [1]
Many people achieve significant weight loss without experiencing headaches, and headaches dont correlate with better or worse results
In addition to inhibiting brain development, reducing IGF-2 affects cell metabolism and stem cell self-renewal (13,14)
Semaglutide's glucose-dependent insulin secretion support and weight-loss-driven insulin sensitivity improvement address prediabetes from two angles simultaneously, with a meaningful probability of preventing progression to diabetes altogether
Working with a provider whose background is in gastrointestinal health can be particularly beneficial, since many of GLP-1s benefits and side effects affect the digestive tract
US$ 21.67
US$ 26.63
US$ 23.93
